Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
6.74
-0.48 (-6.65%)
At close: Aug 7, 2025, 4:00 PM
6.70
-0.04 (-0.59%)
Pre-market: Aug 8, 2025, 7:00 AM EDT

Company Description

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors.

The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021.

Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Indaptus Therapeutics, Inc.
Indaptus Therapeutics logo
CountryUnited States
Founded2000
IndustryBiotechnology
SectorHealthcare
Employees7
CEOJeffrey Meckler

Contact Details

Address:
Three Columbus Circle, 15th Floor
New York, New York 10019
United States
Phone646 427 2727
Websiteindaptusrx.com

Stock Details

Ticker SymbolINDP
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001857044
CUSIP Number45339J105
ISIN NumberUS45339J1051
Employer ID86-3158720
SIC Code2834

Key Executives

NamePosition
Jeffrey A. Meckler J.D.Chief Executive Officer and Director
Dr. Michael J. Newman Ph.D.Founder, Chief Scientific Officer and Director
Walt Addison Linscott Esq.Chief Operating Officer
Dr. Roger J. Waltzman M.B.A., M.D.Chief Medical Officer
Nir SassiChief Financial Officer, Secretary and Treasurer

Latest SEC Filings

DateTypeTitle
Jul 29, 20258-KCurrent Report
Jul 16, 20258-KCurrent Report
Jul 1, 20258-KCurrent Report
Jun 26, 20258-KCurrent Report
Jun 23, 2025DEF 14AOther definitive proxy statements
Jun 20, 2025DNotice of Exempt Offering of Securities
Jun 13, 2025PRE 14AOther preliminary proxy statements
Jun 13, 20258-KCurrent Report
Jun 11, 20258-KCurrent Report
May 14, 202510-QQuarterly Report